1. P121 Characteristics of COPD patients with and without maintenance treatment at baseline, by GOLD stage: TONADO. (12th November 2015) Authors: Korn, S; Abrahams, R; Grönke, L; Korducki, L; Amatto, VC; Buhl, R Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P123 Inhaled corticosteroid plus long-acting β2-agonist therapy is overused in the treatment of patients with chronic obstructive pulmonary disease: post hoc analyses of two 1-year studies. (12th November 2015) Authors: Watz, H; Ferguson, GT; Grönke, L; Voß, F; Abrahams, R; Buhl, R Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P125 Tiotropium plus olodaterol combination therapy provides lung-function benefits when compared to tiotropium alone, irrespective of prior treatment with a long-acting bronchodilator: post hoc analyses of two 1-year studies. (12th November 2015) Authors: Buhl, R; Abrahams, R; Grönke, L; Korducki, L; Fležar, M; Ferguson, GT Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P256 Safety Of Once-daily Tiotropium And Olodaterol Fixed-dose Combination Via The Respimat In Chronic Obstructive Pulmonary Disease In Two 1-year Studies. (10th November 2014) Authors: Buhl, R; Abrahams, R; Bjermer, L; Derom, E; Fležar, M; Hébert, J; Veale, A; Grönke, L; Hamilton, A; Tetzlaff, K; Korducki, L; Huisman, H; Waitere-Wijker, S; McGarvey, L Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P298 Tiotropium/olodaterol therapy provides symptomatic benefits irrespective of prior maintenance treatment: post hoc analyses of the otemto® studies. (15th November 2016) Authors: Abrahams, R; Ferguson, GT; Bjermer, L; Grönke, L; Voß, F; Singh, D Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P299 Effects of symptom severity at baseline on lung-function and sgrq responses in the otemto® studies. (15th November 2016) Authors: Martinez, FJ; Abrahams, R; Ferguson, GT; Bjermer, L; Grönke, L; Voß, F; Singh, D Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P55 Benefits of tiotropium/olodaterol on symptoms and health-related quality of life in patients with moderate to severe COPD with chronic bronchitis and/or emphysema. (15th November 2016) Authors: Ferguson, GT; Abrahams, R; Bjermer, L; Grönke, L; Voß, F; Singh, D Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S61 Analysis of the efficacy and safety of the combination of tiotropium + olodaterol in patients with COPD by previous usage of inhaled corticosteroids. (12th November 2015) Authors: Korn, S; Buhl, R; Grönke, L; Korducki, L; Amato, VC; Ferguson, GT; Abrahams, R Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗